Edition:
United Kingdom

Aeglea Bio Therapeutics Inc (AGLE.OQ)

AGLE.OQ on NASDAQ Stock Exchange Global Market

7.84USD
14 Nov 2018
Change (% chg)

-- (--)
Prev Close
$7.84
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
51,124
52-wk High
$12.00
52-wk Low
$3.75

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.542
Jun '18 2.38 -0.457
Mar '18 1.51 -0.487
FY 2017 Dec '17 1.48 -0.391
Sep '17 1.26 -0.480
Jun '17 1.48 -0.470
Mar '17 0.98 -0.467
FY 2016 Dec '16 1.25 -0.410
Sep '16 1.15 -0.468
Jun '16 1.37 -0.461
Mar '16 0.86 -0.398
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 5 0.86 2.40 0.00 0.00
Quarter Ending Mar-19 3 0.50 1.50 0.00 --
Year Ending Dec-18 5 5.31 6.49 3.89 1.95
Year Ending Dec-19 5 2.43 6.40 0.00 6.01
Earnings (per share)
Quarter Ending Dec-18 5 -0.39 -0.22 -0.52 -0.51
Quarter Ending Mar-19 3 -0.61 -0.43 -0.88 --
Year Ending Dec-18 5 -1.81 -1.49 -2.02 -2.13
Year Ending Dec-19 5 -2.17 -1.48 -3.51 -2.59
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.49 33.64
P/E High - Last 5 Yrs. -- 308.79 45.61
P/E Low - Last 5 Yrs. -- 85.15 23.70
Beta -- 0.93 0.88
Price to Sales (TTM) 18.07 121.71 5.95
Price to Book (MRQ) 1.40 14.77 4.89
Price to Tangible Book (MRQ) 1.40 13.90 6.50
Price to Cash Flow (TTM) -- 66.81 22.90
% Owned Institutions 64.29 13.77 2.15

Dividends

  Company industry sector
Dividend Yield -- 0.41 1.51
Dividend Yield - 5 Year Avg -- 0.31 1.52
Dividend 5 Year Growth Rate -- 2.84 5.41
Payout Ratio(TTM) -- 25.52 43.93

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 7.72 387.07 8.08
Sales (TTM) vs TTM 1 Yr. Ago -0.67 97.70 5.80
Sales - 5 Yr. Growth Rate -- 29.11 9.84
EPS (MRQ) vs Qtr. 1 Yr. Ago -1.90 27.93 23.27
EPS (TTM) vs TTM 1 Yr. Ago -20.52 -- --
EPS - 5 Yr. Growth Rate -- 33.15 10.88
Capital Spending - 5 Yr. Growth Rate -- 36.76 14.85

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.02 2.27
Current Ratio (MRQ) 14.98 5.29 3.07
LT Debt to Equity (MRQ) 0.00 36.70 13.15
Total Debt to Equity (MRQ) 0.00 38.52 17.74
Interest Coverage (TTM) -- -90.95 37.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.04 54.86
Gross Margin - 5 Yr. Avg. -- 48.29 52.38
EBITD Margin (TTM) -508.77 -- --
EBITD - 5 Yr. Avg -- -554.66 10.90
Operating Margin (TTM) -512.56 -797.48 3.24
Operating Margin - 5 Yr. Avg. -- -575.64 6.22
Pre-Tax Margin (TTM) -506.49 -760.60 4.31
Pre-Tax Margin - 5 Yr. Avg. -- -581.03 6.66
Net Profit Margin (TTM) -506.49 -761.46 0.58
Net Profit Margin - 5 Yr. Avg. -- -583.67 2.90
Effective Tax Rate (TTM) -- 25.03 23.26
Effective Tax Rate - 5 Yr. Avg. -- 19.86 24.21

Efficiency

  Company industry sector
Revenue/Employee (TTM) 161,900 22,792,305 803,310,395
Net Income/Employee (TTM) -820,000 1,402,730 94,478,415
Receivable Turnover (TTM) 3.42 19.90 5.78
Inventory Turnover (TTM) -- 2.68 3.71
Asset Turnover (TTM) 0.07 0.42 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -34.06 -1.66 10.86
Return on Assets - 5 Yr. Avg. -- 2.77 11.96
Return on Investment (TTM) -36.00 -0.29 14.22
Return on Investment - 5 Yr. Avg. -- 1.51 15.54
Return on Equity (TTM) -36.04 0.40 15.99
Return on Equity - 5 Yr. Avg. -- 1.96 16.82
  1 Year 3 Year 5 Year
Sales % -23.94 -- --
EPS (TTM) % -119.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aeglea Bio Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 24.07 19.79 84 58
13 Week 57.37 49.71 91 61
26 Week -26.41 -32.01 25 74
52 Week -23.68 -35.31 34 45
YTD 22.64 7.71 60 56
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 74.68%
# of Holders: 98
Total Shares Held: 17,894,831
3 Mo. Net Change: 391,919
# New Positions: 6
# Closed Positions: 5
# Increased Positions: 25
# Reduced Positions: 17
# Net Buyers: 8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.